Nick brings expertise in molecular pharmacology and drug discovery to Scitaris, drawing on experience as a Senior Scientist at Excellerate Bioscience, where he specialized in GPCR pharmacology, kinetics, and pre-clinical oncology programs. He holds a Ph.D. in Molecular Pharmacology and Modern Drug Discovery from the University of Nottingham, where he studied GPCR dimerization and ligand binding kinetics, as well as a BSc and MSc in Bio-Pharmaceutical Sciences from the University of Leiden. At Scitaris, Nick leverages his analytical skills to help clients make data-driven decisions that maximize patient impact.